You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
|
|
|
Home
Albumin
Half-life extension
Hyaluronic acid
Applications
Our science
Contact
Information centre
News & events
SITEMAP
Page Content
Home
Albumin
Applications
Half-life extension
Sealants
Stabilization
Recombumin® Alpha
Handling recommendations
Product specification 10%
Product specification 20%
Recombumin® Prime
Handling recommendations
Product specification
Half-life extension
Albumin-based
Albufuse® Flex
Recombumin® Flex
Days to weeks
Long patent
Regulatory
Track record
Testimonials
Hyaluronic acid
Applications
Aesthetic medicine
Controlled release of drugs
Eye care
Formulation of drugs
Joint care
Other applications
Benefits
Safety
Consistency
Performance
Support
Testimonial
Value
Crosslinking technology
Frequently asked questions
Specifications
850T product specifications
850P product specifications
Handling recommendations
Applications
Medical devices
Sealants & hemostats
Aesthetic medicine
Eye care
Formulation of drugs
Joint care
Drug delivery
Half-life extension
Controlled release of drugs
Stabilization
Our science
Contact
Information centre
Articles
Albumin
Half-life extension
Hyaluronic acid
Brochures and datasheets
Albumin
Half-life extension
Hyaluronic acid
Posters and presentations
Albumin
Half-life extension
Hyaluronic acid
News & events
Upcoming events
Press releases 2012
Press releases 2011
Press releases 2010
Press releases 2009
Press releases 2008
Press releases 2007
CONTACT US
Call +1 617 401 2500
Email us
Request information
Find us
Copyright © 2011 Novozymes. All rights reserved.
Legal disclaimer
|
Sitemap
|
Information centre
|
News & events
|
About us
|
novozymes.com
|